BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koh DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, Fiel MI, Goshima S, Ju SH, Kartalis N, Kudo M, Lee JM, Murakami T, Seidensticker M, Sirlin CB, Tan CH, Wang J, Yoon JH, Zeng M, Zhou J, Taouli B. Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging. Eur Radiol 2021;31:5615-28. [PMID: 33523304 DOI: 10.1007/s00330-020-07637-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng D, Liang C, Zheng Y, Wang X, Liu K, Lin Z, Zhu Q, Zhao X. The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients. Eur Radiol 2022. [PMID: 35639146 DOI: 10.1007/s00330-022-08874-5] [Reference Citation Analysis]
2 Caparroz C, Forner A, Rimola J, Darnell A, García-Criado Á, Ayuso JR, Reig M, Bruix J, Ayuso C. Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR. Radiol Oncol 2022. [PMID: 35776837 DOI: 10.2478/raon-2022-0024] [Reference Citation Analysis]
3 Morisaka H, Seno D, Sakurai Y, Sano K, Akamine Y, Ichikawa T, Okada Y. Quantitative analysis of gadoxetic acid-enhanced MRI for the differential diagnosis of focal liver lesions: Comparison between estimated intralesional gadoxetic acid retention by T1 mapping and conventional processing methods. Eur J Radiol 2021;138:109620. [PMID: 33713905 DOI: 10.1016/j.ejrad.2021.109620] [Reference Citation Analysis]
4 Cho Y, Han YE, Kim MJ, Park BJ, Sim KC, Sung DJ, Han NY, Park YS. Computer-aided Hepatocellular Carcinoma Detection on the Hepatobiliary Phase of Gadoxetic Acid-enhanced Magnetic Resonance Imaging using a Convolutional Neural Network: Feasibility Evaluation with Multi-sequence Data. Computer Methods and Programs in Biomedicine 2022. [DOI: 10.1016/j.cmpb.2022.107032] [Reference Citation Analysis]
5 Kalor A, Girometti R, Maheshwari E, Kierans AS, Pugliesi RA, Buros C, Furlan A. Update on MR Contrast Agents for Liver Imaging. Radiologic Clinics of North America 2022. [DOI: 10.1016/j.rcl.2022.04.005] [Reference Citation Analysis]